What is the onset of action for NPH (Neutral Protamine Hagedorn) insulin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 18, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Onset of Action for NPH Insulin

NPH insulin has an onset of action of approximately 1 hour after subcutaneous injection. 1

Pharmacokinetic Profile of NPH Insulin

NPH (Neutral Protamine Hagedorn) insulin is an intermediate-acting insulin with the following time-action profile:

  • Onset of action: 1 hour 1, 2
  • Peak effect: 6-8 hours 1, 2
  • Duration of action: 12 hours 1

This profile positions NPH insulin between rapid/short-acting insulins and long-acting insulin analogs in terms of onset and duration.

Clinical Implications of NPH's Onset

The 1-hour onset of NPH insulin has important clinical implications:

  • Meal timing: When using NPH for prandial coverage, meals should be timed appropriately relative to injection to avoid early hypoglycemia
  • Bedtime administration: When administered at bedtime, the 1-hour onset means it begins working during the night, which can help control fasting hyperglycemia but also increases risk of nocturnal hypoglycemia 3

Comparison with Other Insulin Types

Insulin Type Onset Peak (hours) Duration (hours)
Rapid-acting (aspart, lispro) 5 minutes 1-2 3-4
Regular insulin 15 minutes 3-4 6-8
NPH 1 hour 6-8 12
Glargine 1 hour None 24

Clinical Applications

Basal-Bolus Regimens

When using NPH as part of a basal-bolus regimen, its 1-hour onset and pronounced peak at 6-8 hours must be considered. Unlike peakless long-acting analogs like glargine, NPH's peak action can cause hypoglycemia if not matched with food intake 1.

Split Evening Dosing

Due to NPH's onset and peak characteristics, splitting the evening insulin regimen (regular insulin at dinner and NPH at bedtime) rather than mixing them before dinner has been shown to:

  • Reduce nocturnal hypoglycemia
  • Improve glycemic control
  • Lower HbA1c values 3

Special Situations

Enteral/Parenteral Feeding

NPH insulin can be administered every 8-12 hours to cover nutritional requirements in patients receiving enteral or parenteral nutrition 4. This dosing schedule aligns with NPH's pharmacokinetic profile.

Glucocorticoid Therapy

NPH insulin is particularly useful for counteracting steroid-induced hyperglycemia because its peak action (4-6 hours) coincides with the peak plasma levels of intermediate-acting glucocorticoids like prednisone 4. For patients on once or twice-daily steroids, NPH is recommended to be administered concomitantly with the steroid dose 4.

Practical Considerations

  • NPH insulin appears uniformly cloudy when properly mixed 5
  • Requires resuspension before administration by gently rolling the vial
  • Can be mixed with rapid-acting or short-acting insulin in the same syringe for immediate use 5
  • Should not be mixed with phosphate-buffered insulins or lente insulins due to potential precipitation 5

Understanding the 1-hour onset of NPH insulin is crucial for proper timing of injections and meal planning to optimize glycemic control while minimizing the risk of hypoglycemia.

Related Questions

When does NPH (Neutral Protamine Hagedorn) insulin peak?
For a 61-year-old man with type 1 diabetes, weight 62.2 kg, normal renal function, currently taking insulin glargine (Lantus) 6 U at 1800 h, with an insulin‑to‑carbohydrate ratio of 1 U per 14 g carbohydrate and an insulin sensitivity factor of 100 mg/dL per unit, and blood glucose values consistently 285–308 mg/dL, what should the insulin sensitivity factor, insulin‑to‑carbohydrate ratio, and basal insulin dose be adjusted to?
For a 65‑year‑old male with type 1 diabetes on neutral protamine Hagedorn insulin (NPH) 22 units at 8 pm, insulin sensitivity factor (ISF) 25 mg/dL per unit, receiving continuous intravenous fluid (IV fluid) at 50 mL/h (increased to 60 mL/h at 4 am) with blood glucose rising from ~273 mg/dL at 8 pm to 353 mg/dL at 7 am, what should his morning NPH dose be and should his ISF be adjusted?
What 8 am dose of NPH (neutral protamine Hagedorn) insulin should be given to a 67‑year‑old male with type 2 diabetes, weight 142 kg, serum creatinine 2.10 mg/dL (GFR 29 mL/min), one week post‑liver transplant, on continuous total feed (201 g carbohydrate per 24 h) with an insulin‑to‑carbohydrate ratio of 1 unit per 10 g carbohydrate but minimal oral intake, who received 20 units of NPH at 8 pm and has been on an insulin drip with rates of 2,2,2,3,3,4,4,3,3,3 units/h since 8 pm and wishes to discontinue the drip?
For a 47-year-old male weighing 120 kg who is being changed from dexamethasone 10 mg every 6 hours to 10 mg every 12 hours, what should the 10 am Neutral Protamine Hagedorn (NPH) dose be, what should the 8 pm NPH dose be, and what should the insulin sensitivity factor (ISF) and insulin-to-carbohydrate ratio (ICR) be?
Can lamotrigine and valproic acid cause impaired renal function?
What can be done about iron supplementation causing stomach pain?
What are the exercise recommendations for different age groups?
What is the recommended oral care regimen for brushing a newborn's gums?
What is the recommended dosage and use of Dexilant (dexlansoprazole) for treating gastroesophageal reflux disease (GERD) and erosive esophagitis?
What is the difference between amlodipine (calcium channel blocker) and nicardipine (calcium channel blocker) in the management of hypertension?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.